SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-025328
Filing Date
2022-07-06
Accepted
2022-07-06 16:05:17
Documents
2
Period of Report
2022-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4131
2 EX-24 DOCUMENT attachment1.htm EX-24 3973
  Complete submission text file 0000899243-22-025328.txt   9484
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Issuer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address
Hering David (Reporting) CIK: 0001875613 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40703 | Film No.: 221068667